Dr. Waugh's Lab Logo MCL Home David S. Waugh National Cancer Institute Home Page Dr. Waugh's Home Page Dr. Waugh's Research Summary Dr. Waugh's Publications Dr. Waugh's Staff Dr. Waugh's Structure Gallery Dr. Waugh's Technical Information
 
E. coli strain BL21(DE3)/pRK1035
 
 Description: This derivative of E. coli BL21(DE3) overproduces the catalytic domain of tobbaco vein mottling virus (TVMV) protease in the form of an MBP fusion protein that cleaves itself in vivo to yield a TVMV protease catalytic domain with an N-terminal His-tag.
   
 Plasmid: The TVMV protease expression vector pRK1035, a derivative of pMal-C2 (New England Biolabs)
   
 Replicon: ColE1 (pBR322)
   
 Antibotic Resistance: Ampicillin
   
 Promotor: tac
   
 Inducer: IPTG (1 mM)
   
 Notes: The specificity of TVMV protease is distinct from that of TEV protease. The canonical recognition site for TVMV protease is ETVRFQS, with cleavage occurring between Q and S. Shifting the temperature from 37 °C to 30 °C during induction maximizes the yield of soluble TVMV protease. The TVMV protease open reading frame on pRK1035 was constructed from synthetic oligonucleotides and has been codon-optimized for expression in E. coli.
   
 Literature Citations: Yoon, H. Y., Hwang, D. C., Choi, K. Y., and Song, B. D. (2000). Proteolytic processing of oligopeptides containing the target sequences by the recombinant tobacco vein mottling virus NIa protease. Mol. Cells 10: 213-219.
   
 Nucleotide Sequence:  
   
 Amino Acid Sequence:
 

SHHHHHHSKALLKGVRDFNPISACVCLLENSSDGHSERLFGIGFGPYIIANQHLFR RNNGELTIKTMHGEFKVKNSTQLQMKPVEGRDIIVIKMAKDFPPFPQKLKFRQPT IKDRVCMVSTNFQQKSVSSLVSESSHIVHKEDTSFWQHWITTKDGQCGSPLVSIID GNILGIHSLTHTTNGSNYFVEFPEKFVATYLDAADGWCKNWKFNADKISWGSFT LVEDAPEDDFMAKKTVAAIMD



MCL Bottom Navigation Bar MCL Home MCL Web Site Map MCL Contact Information MCL Web Disclaimer NCI-FCRDC Web Site NCI-CCR Web Site